ABOUT THE EVENT
Date: Wednesday, April 29, 2026 8am–5:30pm EDT
Event Location: Boston, Massachusetts
Imagine spending a full day surrounded by the leading minds driving biologics production — engineers, scientists, and decision-makers from pharma and biotech, all focused on perfecting antibody manufacturing. That’s exactly what the Antibody Manufacturing Xchange Boston 2026 delivers. It’s an invitation-only, highly curated forum where you get access to top-tier expertise and the opportunity to build meaningful, actionable relationships that can influence your manufacturing strategy and pipeline success.
Over five focused tracks (Cell Line Development, Upstream Development, Downstream Processing & Purification, Formulation & Stability, and Quality Control & Characterization), attendees will tackle the real, often complex challenges of scaling biologics manufacturing. Whether you’re striving for higher cell-line productivity without sacrificing quality, optimizing purification to remove contaminants, ensuring formulation stability for long-term storage, or honing quality-control assays to satisfy regulatory and clinical demands — each track offers deep-dive sessions tailored to those needs.
The day includes keynote-style opening addresses, poster sessions, sponsor-led roundtables, and pre-scheduled one-to-one meetings — all thoughtfully structured to foster collaboration, problem-solving, and partnership development. There’s also time built in for networking: a lunch break, breaks between sessions, and a final reception — making it easy to connect informally with peers facing similar challenges or exploring similar goals.
If your work involves biologics manufacturing — from early-stage development to scale-up and quality assurance — this Xchange offers more than just insights: it delivers access to a community of experts, potential collaborators, and decision-makers who understand what it takes to bring antibody-based therapeutics from lab bench to clinical success. It’s a rare opportunity to accelerate your manufacturing pipeline and stay ahead in a rapidly evolving field.
